BioRem Inc. (TSXV:BRM)
Canada
· Delayed Price · Currency is CAD 1.930
-0.040 (-2.03%)
Apr 29, 2025, 3:59 PM EDT
BioRem Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 3.04 | 2.18 | 1.61 | 1.3 | 2.09 | Upgrade
|
| Depreciation & Amortization | 0.47 | 0.38 | 0.35 | 0.34 | 0.35 | Upgrade
|
| Stock-Based Compensation | 0.14 | 0.13 | 0.09 | 0.01 | 0.02 | Upgrade
|
| Other Operating Activities | 0.47 | 0.54 | 0.12 | 0.43 | 0.56 | Upgrade
|
| Change in Accounts Receivable | 0.24 | -3.04 | -1.72 | -2.53 | -2.53 | Upgrade
|
| Change in Inventory | -1.83 | -0.04 | 0.25 | 0.04 | 0.2 | Upgrade
|
| Change in Accounts Payable | -2.52 | 1.38 | 0.74 | 3.25 | -0.03 | Upgrade
|
| Change in Unearned Revenue | 1.84 | 1.81 | -0.55 | 0.24 | 0.99 | Upgrade
|
| Change in Income Taxes | 0.75 | -0.7 | 0.35 | 0.3 | 0.03 | Upgrade
|
| Change in Other Net Operating Assets | 1.07 | -2.15 | 0.2 | 0.39 | 1.66 | Upgrade
|
| Operating Cash Flow | 3.69 | 0.49 | 1.44 | 3.78 | 3.34 | Upgrade
|
| Operating Cash Flow Growth | 652.01% | -66.09% | -61.79% | 13.11% | 32.28% | Upgrade
|
| Capital Expenditures | -0.37 | -0.55 | -0.2 | -0.08 | -0.34 | Upgrade
|
| Investing Cash Flow | -0.37 | -0.55 | -0.2 | -0.08 | -0.34 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 1.01 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 4 | - | Upgrade
|
| Total Debt Issued | - | - | - | 5.01 | - | Upgrade
|
| Short-Term Debt Repaid | - | -0.78 | -0.23 | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.73 | -0.62 | -0.72 | -0.24 | -0.2 | Upgrade
|
| Total Debt Repaid | -0.73 | -1.4 | -0.95 | -0.24 | -0.2 | Upgrade
|
| Net Debt Issued (Repaid) | -0.73 | -1.4 | -0.95 | 4.77 | -0.2 | Upgrade
|
| Issuance of Common Stock | 0.16 | 0.07 | 0 | 0.08 | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -12.41 | - | Upgrade
|
| Financing Cash Flow | -0.57 | -1.33 | -0.95 | -7.56 | -0.2 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.18 | -0.09 | -0.99 | -0.55 | -0.4 | Upgrade
|
| Net Cash Flow | 2.92 | -1.48 | -0.7 | -4.4 | 2.4 | Upgrade
|
| Free Cash Flow | 3.31 | -0.06 | 1.24 | 3.71 | 3 | Upgrade
|
| Free Cash Flow Growth | - | - | -66.50% | 23.48% | 25.45% | Upgrade
|
| Free Cash Flow Margin | 8.85% | -0.25% | 4.30% | 15.14% | 12.31% | Upgrade
|
| Free Cash Flow Per Share | 0.21 | -0.00 | 0.07 | 0.10 | 0.08 | Upgrade
|
| Levered Free Cash Flow | 2.06 | 0.08 | -0.5 | 3.36 | 1.83 | Upgrade
|
| Unlevered Free Cash Flow | 2.18 | 0.25 | -0.34 | 3.38 | 1.85 | Upgrade
|
| Change in Net Working Capital | 0.81 | 1.63 | 2.38 | -1.65 | -0.4 | Upgrade
|
Updated Nov 6, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.